Results 1 to 10 of about 15,152,607 (398)
Health Promotion and Chronic Disease Prevention in Canada, 2019 Corriger une erreur de référence ayant paru à la page 282 de l’article suivant : Ye X, Sutherland J, Henry B, Tyndall M, Kendall PRW. Aperçu – Impact des décès par surdose de drogue sur l’espérance de vie à la naissance en Colombie-Britannique. Promotion
Health Promotion and Chronic Disease Prevention in Canada editorial team
doaj +4 more sources
Medical Science Monitor, 2023 The 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report includes relevant topics from the clinician’s perspective and evidence published on chronic obstructive pulmonary disease (COPD) since GOLD 2017. The World Health Organization (
D. Parums
semanticscholar +1 more source
The Lancet, 2021 Chronic kidney disease is a progressive disease with no cure and high morbidity and mortality that occurs commonly in the general adult population, especially in people with diabetes and hypertension. Preservation of kidney function can improve outcomes and can be achieved through non-pharmacological strategies (eg, dietary and lifestyle adjustments ...
Kalantar-Zadeh, Kamyar +4 more
openaire +4 more sources
Chronic obstructive pulmonary disease: management of chronic disease [PDF]
Medicine, 2012 Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, affecting an estimated 3 million people in the UK. The most common cause is tobacco smoke. Patients with COPD experience a high symptom burden, worsened during disease instability (termed exacerbations or ‘lung attacks’), and a multidisciplinary approach should ...
Russell, R, Norcliffe, J, Bafadhel, M
openaire +6 more sources
Health Promotion and Chronic Disease Prevention in Canada, 2016 Correction to: Crain J, McFaull S, Thompson W, et al. Status Report – The Canadian Hospitals Injury Reporting and Preventive Program: a dynamic and innovative injury surveillance system. Health Promot Chronic Dis Prev Can. 2016;36(6):112-7.
Health Promotion and Chronic Disease Prevention in Canada editorial team
doaj +5 more sources
The Role of Nutrition in Chronic Disease
Nutrients, 2023 According to the Centers for Disease Control and Prevention, six out of every ten adults in the United States have at least one chronic disease, and about four in ten have two or more chronic diseases [...].
S. Gropper
semanticscholar +1 more source
BMC Public Health, 2023 Background Shenzhen has made great efforts to address the tobacco epidemic in the past decade. This study aims to evaluate the current status of the tobacco epidemic among adolescent in Shenzhen, China.
Bingliang Lin +8 more
doaj +1 more source
Empagliflozin in Patients with Chronic Kidney Disease
New England Journal of Medicine, 2022 Background This study, the EMPA-KIDNEY trial, was designed to assess the effects of empagliflozin in a broad range of patients with chronic kidney disease (CKD) at risk of progression. Methods We randomly assigned 6609 participants to empagliflozin (10mg
W. Herrington +38 more
semanticscholar +1 more source
Is “chronic kidney disease” a disease? [PDF]
Journal of Evaluation in Clinical Practice, 2018 AbstractSeveral philosophers of medicine have attempted to answer the question “what is disease?” In current clinical practice, an umbrella term “chronic kidney disease” (CKD) encompasses a wide range of kidney health states from commonly prevalent subclinical, asymptomatic disease to rare end‐stage renal disease requiring transplant or dialysis to ...
Smart, B, Stevens, R, Verbakel, J
openaire +4 more sources
Dapagliflozin in Patients with Chronic Kidney Disease.
New England Journal of Medicine, 2020 BACKGROUND Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, with or without type 2 diabetes, is not known.
H. Heerspink +13 more
semanticscholar +1 more source